Autonomous Intravenous Therapy Administration (A Pilot Study)
Principal Investigator: Martin Yarmush
Affiliation: Paul & Mary Monroe Chair & Distinguished Professor, Biomedical Engineering
Amount: $103,246
Sponsor: Novo Nordisk, Inc.
Principal Investigator: Martin Yarmush
Affiliation: Paul & Mary Monroe Chair & Distinguished Professor, Biomedical Engineering
Amount: $103,246
Sponsor: Novo Nordisk, Inc.